Personalized lifestyle medicine: relevance for nutrition and lifestyle recommendations

Deanna M Minich, Jeffrey S Bland, Deanna M Minich, Jeffrey S Bland

Abstract

Public health recommendations for lifestyle modification, including diet and physical activity, have been widely disseminated for the prevention and treatment of disease. These guidelines are intended for the overall population without significant consideration for the individual with respect to one's genes and environment. Personalized lifestyle medicine is a newly developed term that refers to an approach to medicine in which an individual's health metrics from point-of-care diagnostics are used to develop lifestyle medicine-oriented therapeutic strategies for improving individual health outcomes in managing chronic disease. Examples of the application of personalized lifestyle medicine to patient care include the identification of genetic variants through laboratory tests and/or functional biomarkers for the purpose of designing patient-specific prescriptions for diet, exercise, stress, and environment. Personalized lifestyle medicine can provide solutions to chronic health problems by harnessing innovative and evolving technologies based on recent discoveries in genomics, epigenetics, systems biology, life and behavioral sciences, and diagnostics and clinical medicine. A comprehensive, personalized approach to medicine is required to promote the safety of therapeutics and reduce the cost of chronic disease. Personalized lifestyle medicine may provide a novel means of addressing a patient's health by empowering them with information they need to regain control of their health.

Figures

Figure 1
Figure 1
Lifestyle-induced chronic disease.
Figure 2
Figure 2
The trajectory of disease and role for personalized lifestyle medicine.
Figure 3
Figure 3
What is personalized lifestyle medicine?

References

    1. Egger GJ, Binns AF, Rossner SR. The emergence of “lifestyle medicine” as a structured approach for management of chronic disease. Medical Journal of Australia. 2009;190(3):143–145.
    1. Dysinger WS. Lifestyle medicine competencies for primary care physicians. Virtual Mentor. 2013;15(4):306–310.
    1. Lianov L, Johnson M. Physician competencies for prescribing lifestyle medicine. Journal of the American Medical Association. 2010;304(2):202–203.
    1. Egger G, Binns A, Rossner S. Lifestyle Medicine. Sydney, Australia: McGraw-Hill; 2008.
    1. Herman WH, Hoerger TJ, Brandle M, et al. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Annals of Internal Medicine. 2005;142(5):323–332.
    1. Department of Agriculture US, Department of Health and Human Services US. Dietary Guidelines For Americans. 7th edition. Washington, DC, USA: U.S. Government Printing Office; 2010.
    1. American Heart Association Nutrition Committee, Lichtenstein AH, Appel LJ, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American heart association nutrition committee. Circulation. 2006;114(1):82–96.
    1. Kushi LH, Doyle C, McCullough M, et al. American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer Journal for Clinicians. 2012;62(1):30–67.
    1. American Diabetes Association, Bantle JP, Wylie-Rosett J, et al. Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2008;31(supplement 1):S61–S78.
    1. Xie G, Li X, Li H, Jia W. Toward personalized nutrition: comprehensive phytoprofiling and metabotyping. Journal of Proteomic Research. 2013;12(4):1547–1559.
    1. Jacobs DR, Tapsell LC. Food synergy: the key to a healthy diet. Proceedings of the Nutrition Society. 2013;72(2):200–206.
    1. Minich DM, Bland JS. Dietary management of the metabolic syndrome beyond macronutrients. Nutrition Reviews. 2008;66(8):429–444.
    1. Santos PC, Krieger JE, Pereira AC. Molecular diagnostic and pathogenesis of hereditary hemochromatosis. International Journal of Molecular Sciences. 2012;13(2):1497–1511.
    1. Mocchegiani E, Giacconi R, Costarelli L, et al. Zinc deficiency and IL-6 -174G/C polymorphism in old people from different European countries: effect of zinc supplementation. ZINCAGE study. Experimental Gerontology. 2008;43(5):433–444.
    1. Neyestani TR, Djazayery A, Shab-Bidar S, et al. Vitamin D receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care. 2013;36(3):550–556.
    1. Fischer A, Schmelzer C, Rimbach G, Niklowitz P, Menke T, Döring F. Association between genetic variants in the Coenzyme Q10metabolism and Coenzyme Q10status in humans. BMC Research Notes. 2011;4, article 245
    1. Horvath R, Czermin B, Gulati S, et al. Adult-onset cerebellar ataxia due to mutations in CABC1/ADCK3. Journal of Neurology, Neurosurgery and Psychiatry. 2012;83(2):174–178.
    1. Lizer MH, Bogdan RL, Kidd RS. Comparison of the frequency of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in depressed versus nondepressed patients. Journal of Psychiatric Practice. 2011;17(6):404–409.
    1. Swartz MD, Peterson CB, Lupo PJ, et al. Investigating multiple candidate genes and nutrients in the folate metabolism pathway to detect genetic and nutritional risk factors for lung cancer. Plos One. 2013;8(1, article e53475)
    1. Block G, Shaikh N, Jensen CD, Volberg V, Holland N. Serum vitamin C and other biomarkers differ by genotype of phase 2 enzyme genes GSTM1 and GSTT. The American Journal of Clinical Nutrition. 2011;94(3):929–937.
    1. Maehashi K, Huang L. Bitter peptides and bitter taste receptors. Cellular and Molecular Life Sciences. 2009;66(10):1661–1671.
    1. Feeney E, O’Brien S, Scannell A, Markey A, Gibney ER. Genetic variation in taste perception: does it have a role in healthy eating? Proceedings of the Nutrition Society. 2011;70(1):135–143.
    1. Magee PJ, Rowland I. Soy products in the management of breast cancer. Current Opinion in Clinical Nutrition & Metabolic Care. 2012;15(6):586–591.
    1. Hunter JO. Food allergy—or enterometabolic disorder? The Lancet. 1991;338(8765):495–496.
    1. Valeur J, Morken MH, Norin E, Midtvedt T, Berstad A. Intestinal fermentation in patients with self-reported food hypersensitivity: painful, but protective? Clinical and Experimental Gastroenterology. 2010;3(1):65–70.
    1. Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. The American Journal of Gastroenterology. 2013;108:656–676.
    1. Batur-Caglayan HZ, Irkec C, Yildirim-Capraz I, Atalay-Akyurek N, Dumlu S. A case of multiple sclerosis and celiac disease. Case Reports in Neurological Medicine. 2013;2013:3 pages.576921
    1. Haghighi AB, Ansari N, Mokhtari M, Geramizadeh B, Lankarani KB. Multiple sclerosis and gluten sensitivity. Clinical Neurology and Neurosurgery. 2007;109(8):651–653.
    1. Tengah CDP, Lock RJ, Unsworth DJ, Wills AJ. Multiple sclerosis and occult gluten sensitivity. Neurology. 2004;62(12):2326–2327.
    1. Rodrigo L, Hernández-Lahoz C, Fuentes D, Alvarez N, López-Vázquez A, González S. Prevalence of celiac disease in multiple sclerosis. BMC Neurology. 2011;11(article 31)
    1. Hadjivassiliou M, Grünewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. The Lancet. 1998;352(9140):1582–1585.
    1. Pellecchia MT, Scala R, Perretti A, et al. Cerebellar ataxia associated with subclinical celiac disease responding to gluten-free diet. Neurology. 1999;53(7):1606–1608.
    1. Bürk K, Bösch S, Müller CA, et al. Sporadic cerebellar ataxia associated with gluten sensitivity. Brain. 2001;124(part 5):1013–1019.
    1. Wills AJ, Unsworth DJ. The neurology of gluten sensitivity: separating the wheat from the chaff. Current Opinion in Neurology. 2002;15(5):519–523.
    1. Hadjivassiliou M, Davies-Jones GAB, Sanders DS, Grünewald RA. Dietary treatment of gluten ataxia. Journal of Neurology, Neurosurgery and Psychiatry. 2003;74(9):1221–1224.
    1. Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grünewald RA. Gluten ataxia. The Cerebellum. 2008;7(3):494–498.
    1. Liu C-S, Soong B-W, Lee Y-C, et al. Gluten sensitivity: associated sporadic cerebellar ataxia in Taiwan. Acta Neurologica Taiwanica. 2010;19(4):263–269.
    1. Hadjivassiliou M, Aeschlimann P, Sanders DS, et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. 2013;80(19):1740–1745.
    1. Collin P, Pirttilä T, Nurmikko T, Somer H, Erilä T, Keyriläinen O. Celiac disease, brain atrophy, and dementia. Neurology. 1991;41(3):372–375.
    1. Wills AJ. The neurology and neuropathology of coeliac disease. Neuropathology and Applied Neurobiology. 2000;26(6):493–496.
    1. Freeman HJ. Neurological disorders in adult celiac disease. The Canadian Journal of Gastroenterology. 2008;22(11):909–911.
    1. Hu WT, Murray JA, Greenaway MC, Parisi JE, Josephs KA. Cognitive impairment and celiac disease. Archives of Neurology. 2006;63(10):1440–1446.
    1. Hadjivassiliou M, Gibson A, Davies-Jones GAB, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness? The Lancet. 1996;347(8998):369–371.
    1. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106(21):2747–2757.
    1. Liang S, Steffen LM, Steffen BT, et al. APOE genotype modifies the association between plasma omega-3 fatty acids and plasma lipids in the Multi-Ethnic Study of Atherosclerosis (MESA) Atherosclerosis. 2013;9150(13):00114–00017.
    1. Olano-Martin E, Anil E, Caslake MJ, et al. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis. 2010;209(1):104–110.
    1. Sanada H, Jones JE, Jose PA. Genetics of salt-sensitive hypertension. Current Hypertension Reports. 2011;13(1):55–66.
    1. Gu D, Zhao Q, Kelly TN, et al. The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure: the GenSalt Study. The American Journal of Epidemiology. 2012;176(supplement 7):S72–S80.
    1. Rebholz CM, Gu D, Chen J, et al. Physical activity reduces salt sensitivity of blood pressure: the Genetic Epidemiology Network of Salt Sensitivity Study. The American Journal of Epidemiology. 2012;176(supplement 7):S106–S113.
    1. Fernandez ML. Rethinking dietary cholesterol. Current Opinion in Clinical Nutrition & Metabolic Care. 2012;15(2):117–121.
    1. Kratz M. Dietary cholesterol, atherosclerosis and coronary heart disease. Handbook of Experimental Pharmacology. 2005;(170):195–213.
    1. Rong Y, Chen L, Zhu T, et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. The British Medical Journal. 2013;346(article e8539)
    1. Buford TW, Roberts MD, Church TS. Toward exercise as personalized medicine. Sports Medicine. 2013;43(3):157–165.
    1. Pérusse L, Rankinen T, Hagberg JM, et al. Advances in exercise, fitness, and performance genomics in 2012. Medicine and Science in Sports and Exercise. 2013;45(5):824–831.
    1. Williams PT, Thompson PD. Walking versus running for hypertension, cholesterol, and diabetes mellitus risk reduction. Arteriosclerosis, Thrombosis and Vascular Biology. 2013
    1. Rankinen T, Sung YJ, Sarzynski MA, Rice TK, Rao DC, Bouchard C. Heritability of submaximal exercise heart rate response to exercise training is accounted for by nine SNPs. Journal of Applied Physiology. 2012;112(5):892–897.
    1. Ahmetov II, Williams AG, Popov DV, et al. The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypes. Human Genetics. 2009;126(6):751–761.
    1. Hagberg JM, Rankinen T, Loos RJ, et al. Advances in exercise, fitness, and performance genomics in 2010. Medicine and Science in Sports and Exercise. 2011;43(5):743–752.
    1. Chainani-Wu N, Weidner G, Purnell DM, et al. Changes in emerging cardiac biomarkers after an intensive lifestyle intervention. The American Journal of Cardiology. 2011;108(4):498–507.
    1. Dusek JA, Otu HH, Wohlhueter AL, et al. Genomic counter-stress changes induced by the relaxation response. Plos One. 2008;3(7)e2576
    1. Black DS, Cole SW, Irwin MR, et al. Yogic meditation reverses NF-κB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology. 2013;38(3):348–355.
    1. Zhang TY, Labonté B, Wen XL, Turecki G, Meaney MJ. Epigenetic mechanisms for the early environmental regulation of hippocampal glucocorticoid receptor gene expression in rodents and humans. Neuropsychopharmacology. 2013;38(1):111–123.
    1. Karatoreos IN, McEwen BS. Annual research review: the neurobiology and physiology of resilience and adaptation across the life course. Journal of Child Psychology and Psychiatry. 2013;54(4):337–347.
    1. Bagdy G, Juhasz G, Gonda X. A new clinical evidence-based gene-environment interaction model of depression. Neuropsychopharmacologia Hungarica. 2012;14(4):213–220.
    1. Norrholm SD, Jovanovic T, Smith AK, et al. Differential genetic and epigenetic regulation of catechol-O-methyltransferase is associated with impaired fear inhibition in posttraumatic stress disorder. Frontiers in Behavioral Neuroscience. 2013;7(article 30)
    1. Petersen IT, Bates JE, Goodnight JA, et al. Interaction between serotonin transporter polymorphism (5-HTTLPR) and stressful life events in adolescents' trajectories of anxious/depressed symptoms. Developmental Psychology. 2012;48(5):1463–1475.
    1. de Mel S, Nordlind K, Holst M, Frohm-Nilsson M, Lonne-Rahm SB. Polymorphisms in the serotonin transporter gene of patients with atopic dermatitis-association with personality traits related to high level of anxiety. Immunopharmacology and Immunotoxicology. 2012;34(3):534–538.
    1. Rappaport SM. Implications of the exposome for exposure science. Journal of Exposure Science and Environmental Epidemiology. 2011;21(1):5–9.
    1. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology Biomarkers and Prevention. 2005;14(8):1847–1850.
    1. Pleil JD. Categorizing biomarkers of the human exposome and developing metrics for assessing environmental sustainability. Journal of Toxicology and Environmental Health B. 2012;15(4):264–280.
    1. Gong KW, Zhao W, Li N, et al. Air-pollutant chemicals and oxidized lipids exhibit genome-wide synergistic effects on endothelial cells. Genome Biology. 2007;8(7, article R149)
    1. Hectors TLM, Vanparys C, van der Ven K, et al. Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia. 2011;54(6):1273–1290.
    1. Everett CJ, Frithsen I, Player M. Relationship of polychlorinated biphenyls with type 2 diabetes and hypertension. Journal of Environmental Monitoring. 2011;13(2):241–251.
    1. Lim S, Cho YM, Park KS, Lee HK. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Annals of the New York Academy of Sciences. 2010;1201:166–176.
    1. Wu H, Bertrand KA, Choi AL, et al. Persistent organic pollutants and type 2 diabetes: a prospective analysis in the nurses' health study and meta-analysis. Environmental Health Perspectives. 2013;121(2):153–161.
    1. Thayer KA, Heindel JJ, Bucher JR, Gallo MA. Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environmental Health Perspectives. 2012;120(6):779–789.
    1. Porta M, Pumarega J, Gasull M. Number of persistent organic pollutants detected at high concentrations in a general population. Environment International. 2012;44(1):106–111.
    1. McGraw J, Waller D. Cytochrome P450 variations in different ethnic populations. Expert Opinion on Drug Metabolism & Toxicology. 2012;8(3):371–382.
    1. Sirivarasai J, Wananukul W, Kaojarern S, et al. Association between inflammatory marker, environmental lead exposure, and glutathione S-transferase gene. BioMed Research International. 2013;2013:6 pages.474963
    1. Görman U, Mathers JC, Grimaldi KA, Ahlgren J, Nordström K. Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition. Genes and Nutrition. In press.
    1. Nielsen DE, El-Sohemy A. A randomized trial of genetic information for personalized nutrition. Genes and Nutrition. 2012;7(4):559–566.
    1. Shah T, Zabaneh D, Gaunt T, et al. Gene-centric analysis identifies variants associated with interleukin-6 levels and shared pathways with other inflammation markers. Circulation Cardiovascular Genetics. 2013;6(2):163–170.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj